Age, Biography and Wiki

Stephen J. Benkovic was born on 20 April, 1938 in Orange, New Jersey, U.S., is an American chemist. Discover Stephen J. Benkovic's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 85 years old?

Popular As N/A
Occupation N/A
Age 85 years old
Zodiac Sign Aries
Born 20 April, 1938
Birthday 20 April
Birthplace Orange, New Jersey, U.S.
Nationality United States

We recommend you to check the complete list of Famous People born on 20 April. He is a member of famous with the age 85 years old group.

Stephen J. Benkovic Height, Weight & Measurements

At 85 years old, Stephen J. Benkovic height not available right now. We will update Stephen J. Benkovic's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.

Family
Parents Not Available
Wife Not Available
Sibling Not Available
Children Not Available

Stephen J. Benkovic Net Worth

His net worth has been growing significantly in 2023-2024. So, how much is Stephen J. Benkovic worth at the age of 85 years old? Stephen J. Benkovic’s income source is mostly from being a successful . He is from United States. We have estimated Stephen J. Benkovic's net worth, money, salary, income, and assets.

Net Worth in 2024 $1 Million - $5 Million
Salary in 2024 Under Review
Net Worth in 2023 Pending
Salary in 2023 Under Review
House Not Available
Cars Not Available
Source of Income

Stephen J. Benkovic Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia
Imdb

Timeline

Stephen James Benkovic is an American chemist known for his contributions to the field of enzymology.

He holds the Evan Pugh University Professorship and Eberly Chair in Chemistry at The Pennsylvania State University. He has developed boron compounds that are active pharmacophores against a variety of diseases.

Benkovic has concentrated on the assembly and kinetic attributes of the enzymatic machinery that performs DNA replication, DNA repair, and purine biosynthesis.

Benkovic was born in Orange, New Jersey, USA.

1960

He attended Lehigh University, where he received his B.S. in Chemistry and A.B. degree in English literature in 1960.

1963

He then earned his Ph.D. in Organic Chemistry from Cornell University in 1963.

1964

He was a Postdoctoral Research Associate at the University of California at Santa Barbara from 1964-65.

1965

In 1965, he became a member of the Chemistry Department at Penn State University, and later in 1970, he was promoted to the position of Full Professor of Chemistry.

1977

He received further recognition in 1977 as an Evan Pugh Professor of Chemistry and in 1988 as the holder of the Eberly Chair in Chemistry.

Benkovic has made contributions that have impacted our understanding of biological processes.

He was among the first to hypothesize that conformational changes outside an enzyme’s active site were necessary for achieving maximal catalysis.

This was illustrated in his studies on dihydrofolate reductase (DHFR) that identified dynamic structural changes and their time scale that optimized the enzyme turnover.

He showed how multi-enzyme complexes are assembled to achieve specificity and function and where several activities are present how they are integrated.

This was accomplished in his studies on DNA replication that featured the assembly, disassembly and function of the T4 replisome that coordinates DNA replication.

Benkovic discovered the first example of a reversible metabolon, the purinosome in de novo purine biosynthesis, that only assembles in response to cellular demands and acts temporally and spatially to deliver needed metabolites to cellular constituents.

Conformational Movements

A major theme of Benkovic’s research has been understanding the source of the efficiency of enzymatic catalysis.

He first dissected into individual steps the catalytic cycle used by dihydrofolate reductase (DHFR) using pre-steady-state methods and then tied the contribution of various amino acids, both within and outside the active site, to specific steps.

Significant changes in the rates of hydride transfer were not limited to active-site residues, nor were the effects of multiple mutations additive in terms of free energy.

The amide backbone and side chains of these distal residues were found by NMR to be in regions of high frequency motion (n-psec) and by molecular dynamic simulations the motions of these distal residues were found to be coupled.

Genomic analysis of multiple DHFR sequences revealed low overall DNA sequence homology (30%), but surprisingly high conservation in the same regions whose amino acids had been implicated in catalysis by kinetic analysis, NMR measurements, and molecular dynamics simulations.

The latter directly incorporated these distal residues into a network that acted along the reaction coordinate to facilitate the hydride transfer.

This concept was further elaborated to posit that the measured rates of steps that constitute the turnover cycle of DHFR represent the rates of the conformational changes required to execute the chemical transformation.

The enzymic reaction is not limited by the energetics of the chemical reaction but by the mechanics of sampling that occur within the enzyme substrate complex.

This concept of biological catalysis has the enzyme’s highly-pre-organized Michaelis complex with its active-site residues and substrates juxtaposed by using the dynamics of the protein fold to sample substrate and active site conformations in order to find those optimal for the chemical transformation.

The actual chemistry of bond breaking and forming is fast relative to the sampling process.

Only a small change triggered by movement within the protein fold along a network of coupled residues is needed to surmount the reaction barrier.

The protein fold dictates the type of chemistry that a class of enzymes can accomplish (a rationale for the common mechanistic element extent in protein super-families); allosteric effects are a consequence of creating or inhibiting such networks and drugs can be designed that target such networks.

It also explains the generally low catalytic activity of more rigid structures such as macrocycles and antibodies.

A multi-enzyme complex for the replication of DNA—the T4 replisome

Of particular importance is how multiple protein systems such as the replisomes responsible for DNA replication function where protein-protein interactions create a large catalytic network.

The T4 replisome can be assembled in vitro from eight separate proteins into the four units that catalyze leading and lagging strand synthesis at a replication fork.

With a functioning replisome capable of leading/lagging strand synthesis in hand, key discoveries of broad interest applicable to other replisomes were made.

Firstly the polymerase actively exchanges in/out of the two holoenzymes within the replisome thus providing a  “remodeling” flexibility for the repair of stalled replication forks that occur on damaged DNA strands by other lesion bypass polymerases.

Secondly, two mechanisms dictate Okazaki fragment length: the classical collision mechanism where a finished Okazaki fragment abuts the previous one releasing the lagging strand polymerase and the signaling mechanism where the lagging strand polymerase recycles before the completion of the previous Okazaki fragment.

This feature is essential to maintain coordinated leading/lagging strand synthesis.

De Novo Purine Biosynthesis by a Purinosome Metabolon

A longstanding question in cellular metabolism is how metabolic enzymes in a given network organize within the cytosol, densely packed with myriad proteins and metabolites, to facilitate metabolic flux.

One solution is through the formation of a macromolecular complex of enzymes, termed a ‘metabolon’.

The de novo purine biosynthetic pathway is a highly conserved, energy-intensive pathway that generates inosine 5ᶦ-monophosphate (IMP) from phosphoribosylpyrophosphate (PRPP).